NEW E INNOVATION
DEAD

Serial Number

87328244

Owner

New B Innovation Limited

Attorney

Timothy T. Wang

Filing Date

Feb 8, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NEW E INNOVATION Trademark

Serial Number: 87328244

NEW E INNOVATION is a trademark filed by New B Innovation Limited on February 8, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

New B Innovation Limited (25 trademarks)

17/F., Chevalier Commercial Centre
Hong Kong , HK

Entity Type: 03

Trademark Details

Filing Date

February 8, 2017

Registration Date

Not Registered

Published for Opposition

March 13, 2018

Goods & Services

professional educational services, namely, conducting symposia, conferences, classes, seminars, workshops, forums, demonstrations, advisory groups, and medical congresses, namely, periodic meetings at which medical specialists or experts discuss important treatment guidelines, trends and news updates, all in the field of cardiovascular diseases, neurological diseases, oncological diseases, blood disorder, ischaemia, hypoxia, shock, anemia, hemorrhage, cancer, ischaemic reperfusion injury, brain injury, general surgery, and amino acid dependent diseases, amino acid related disorders

Pharmaceutical and veterinary preparations for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; sanitary preparations for medical purposes; dietetic substances adapted for medical or veterinary use, food for babies; plasters for medical purposes; adjuvants for medical purposes; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; biological preparations for medical purposes, namely, the treatment of cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; biological preparations for veterinary purposes, namely, the treatment of cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; capsules for pharmaceutical purposes sold empty; capsules for pharmaceutical purposes, filled with pharmaceuticals for the treatment of cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; chemical preparations for medical purposes, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; chemical preparations for veterinary purposes, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; chemical preparations for pharmaceutical purposes, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; chemical preparations for veterinary purposes, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; medicines for human purposes, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; medicines for veterinary purposes, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; pharmaceutical preparations, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders; veterinary preparations, namely, for cancers, oncological diseases, neurological diseases, amino acid dependent diseases, amino acid related disorders

Medical services, namely, healthcare services in the nature of medical clinic services and physical therapy services; veterinary services; agricultural services, namely, animal breeding; horticultural services; professional medical advisory and consulting services, namely, providing medical specialist's and medical expert's opinions on medical treatment; patient medical information services, namely, providing call center services, support groups and clubs to provide information in the fields of cardiovascular diseases, neurological diseases, oncological diseases, blood disorder, ischaemia, hypoxia, shock, anemia, hemorrhage, cancer, ischaemic reperfusion injury, brain injury, general surgery, and amino acid dependent diseases, amino acid related disorders; patient medical information services, namely, providing a website featuring streaming videos and information in the field of cardiovascular diseases, neurological diseases, oncological diseases, blood disorder, ischaemia, hypoxia, shock, anemia, hemorrhage, cancer, ischaemic reperfusion injury, brain injury, general surgery, and amino acid dependent diseases, amino acid related disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 10, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 10, 2018 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 8, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 5, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 5, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 5, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 5, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2018 CRFA
ASSIGNED TO LIE
Jan 31, 2018 ALIE
NOTICE OF REVIVAL - E-MAILED
Jan 20, 2018 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2018 TROA
PETITION TO REVIVE-GRANTED
Jan 19, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 19, 2018 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 1, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 1, 2017 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 5, 2017 GNRN
NON-FINAL ACTION E-MAILED
May 5, 2017 GNRT
NON-FINAL ACTION WRITTEN
May 5, 2017 CNRT
ASSIGNED TO EXAMINER
May 4, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 14, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2017 NWOS
NEW APPLICATION ENTERED
Feb 13, 2017 NWAP